Although the Central Dogma was first stated by Francis Crick over a half-century ago, we're still learning exactly how transcription and translation are orchestrated in cells.

STAP (Stimulus-triggered acquisition of pluripotency) cells have made recent science headlines with reports that mouse somatic cells can be reprogrammed into pluripotent cells simply by being subjected to external stress.

A recent publication in Science Translational Medicine describes the use of a humanized monoclonal antibody against activated FXIIa, identified using phage display, to prevent the formation of blood clots without increasing the risk of bleeding.

Membrane protein expression remains a bottleneck in its characterization and structure determination.

In a recent paper published in Nature Chemical Biology, new crystal structures provide insights into the evolution and activity of the AdoMet radical enzyme family that plays a critical role in purine biosynthesis.

Bioactive milk peptides have potential in the treatment of a number of ailments including cancer and diabetes.

For over a decade, the development of potent protease inhibitors, like the breakthrough drug Bortezomib, have been an important therapuetic strategy of cancer drug development.

GenScript, the world’s largest provider of synthetic genes, has launched a new GenPlus™ Next-Generation Gene Synthesis service, which offers unmatched capacity and cost-efficiency for custom gene synthesis.

Protein C (HPC4) tag encodes residues 6 through 17 of the protein C heavy chain.

Gene Therapy is experiencing a resurgence in both the research and pharmaceutical communities.

GenScript is pleased to announce that it will participate in the Synthetic Yeast Genome Sc2.0 Project, initiated and organized by Dr. Jef Boeke of Johns Hopkins University’s (JHU) School of Medicine.

“GenScript has cemented an alliance with AMDeC, LLC, and is the first supplier to close a purchasing deal with AMDeC’s new Group Purchasing Organization (GPO) that is specifically targeting research products and services.

As a compliment to their successful BacPower™ and MamPower™ packages, GenScript USA Incorporation has launched a new PROTential protein expression evaluation service.